11/11/2024

Vasopressin Injection

Products Affected - Description

- Vasopressin injection, American Regent, 20 units/mL, 10 mL vial, 1 count, NDC 00517-1030-01
- Vasopressin injection, Eugia US, 20 units/mL, 1 mL vial, 1 count, NDC 55150-0371-01 - discontinued
- Vasopressin injection, Fresenius Kabi, 20 units/mL, 1 mL RFID vial, 25 count, NDC 63323-0039-01

Reason for the Shortage

- American Regent did not provide a reason for the shortage.
- Amneal has vasopressin injection available.
- Amphastar has vasopressin injection available.
- Eagle has discontinued vasopressin injection.
- Eugia has vasopressin injection available.
- Fresenius Kabi did not provide a reason for the shortage.
- Long Grove Pharmaceuticals has vasopressin premixed vials available.
- Par has Vasostrict available.

Available Products

- Vasostrict injection, Par Pharmaceuticals, 0.2 units/mL, 100 mL vial, 10 count, NDC 42023-0237-10
- Vasostrict injection, Par Pharmaceuticals, 0.4 units/mL, 100 mL vial, 10 count, NDC 42023-0219-10
- Vasostrict injection, Par Pharmaceuticals, 20 units/mL, 1 mL vial, 10 count, NDC 42023-0164-10
- Vasostrict injection, Par Pharmaceuticals, 20 units/mL, 1 mL vial, 25 count, NDC 42023-0164-25
- Vasopressin injection, American Regent, 20 units/mL, 1 mL vial, 25 count, NDC 00517-1020-25
- Vasopressin injection, Amneal, 20 units/mL, 1 mL vial, 25 count, NDC 70121-1642-05
- Vasopressin injection, Amphastar, 20 units/mL, 1 mL vial, 10 count, NDC 00548-9701-00
- Vasopressin injection, Eugia US, 20 units/mL, 1 mL vial, 25 count, NDC 55150-0370-25
- Vasopressin injection, Fresenius Kabi, 20 units/mL, 1 mL vial, 25 count, NDC 63323-0930-01
- Vasopressin injection, Long Grove Pharmaceuticals, 0.2 units/mL, 100 mL vial, 10 count, NDC 81298-8552-03
- Vasopressin injection, Long Grove Pharmaceuticals, 0.4 units/mL, 100 mL vial, 10 count, NDC 81298-8554-03

Estimated Resupply Dates

- American Regent has vasopressin 20 units/mL 10 mL vials on back order and the company cannot estimate a release date.
- Fresenius Kabi has vasopressin 20 units/mL 1 mL RFID vials on back order and the company cannot estimate a release date.

Updated

Updated November 11, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 27, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.